What Happened?
Irvine, CA-based Beta Bionics Retired Michael Rosinko as Chief Technology Officer
About the Company
Beta Bionics is a clinical stage medical technology company focused on the design, development, and commercialization of its iLet® Bionic Pancreas System. The iLet Bionic Pancreas is designed to use adaptive, self-learning, control algorithms, together with continuous glucose monitoring and pump technology, to autonomously compute and administer doses of insulin and/or glucagon and mimic the body`s natural ability to maintain tight glycemic control. Beta Bionics is a for-profit, public benefit corporation and Certified B Corporation™. Since its founding in 2015, its mission has been to help improve health outcomes and the quality of life of children and adults living with diabetes and other conditions of glycemic dysregulation.
About the Person
Michael Rosinko is Chief Technology Officer at Beta Bionics. Previously, Michael held various senior IT leadership roles in the industry.
Info Source
News
Short Profile